Chemours
The Billion-Dollar Gamble: Why Alta Fundamental Advisers is Doubling Down on a Battered Chemours
In the high-stakes world of hedge fund management, few strategies are as nerve-wracking—or potentially lucrative—as the contrarian "deep value" play. This month, the spotlight has fallen on Alta Fundamental Advisers, a New York-based firm led by Nicholas S. Danaher, which has disclosed a massive new position